-
PPM-18: Mapping NF-κB–iNOS Control
2026-09-10
PPM-18 is an iNOS expression inhibitor that connects NF-κB signaling pathway inhibition with measurable inflammatory outputs. This article develops a rigorous assay strategy and explains how bone-remodeling research can inform, but not overstate, PPM-18 applications in sepsis research and inflammation modulation.
-
p21-ELP Delivery Suppresses Glioblastoma
2026-09-10
The reference study shows that the engineered p21-ELP1-Bac construct can enter U87, GBM43, and GBM6 glioblastoma cells and suppress proliferation, primarily through cytostatic rather than strongly apoptotic effects. Its value lies in combining a p21-derived cell-cycle inhibitor with an elastin-like polypeptide and cell-penetrating module, while revealing meaningful differences in sensitivity among glioblastoma models.
-
Angiotensin II in Vascular Aging Research
2026-09-09
Build reproducible endothelial senescence, vascular remodeling, and abdominal aortic aneurysm workflows with a defined Angiotensin II peptide stimulus. This guide connects receptor-proximal signaling to MFN2, mitochondrial, and senescence readouts while providing practical dosing, handling, and troubleshooting strategies.
-
Glycogen Colorimetric Assay Kit II in Exercise Biology
2026-09-09
The Glycogen Colorimetric Assay Kit II enables interference-conscious glycogen measurement in exercise and circadian studies. This article explains how its hydrolysis-based chemistry can clarify what endurance-training data do—and do not—reveal about glycogen biology.
-
Reserpine (N1867): Practical Lab Guide
2026-09-08
Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. Its water and ethanol insolubility, DMSO-dependent preparation, and potent biological activity require controlled handling; it is not intended for diagnostic, therapeutic, clinical, or veterinary use.
-
Reactive Oxygen Species Assay Kit for FLASH-RT
2026-09-08
Use live-cell DCFH-DA fluorescence to connect radiation exposure with oxidative stress, cytotoxicity, and downstream biology. This workflow translates the FLASH-RT nanoparticle findings into practical ROS controls, time-course experiments, and troubleshooting decisions for cancer research oxidative stress studies.
-
Taihangia rupestris: UPLC-MS/MS and Bioactivity
2026-09-07
A 2026 RSC Advances study integrated UPLC-MS/MS, multivariate analysis, complementary antioxidant assays, α-glucosidase inhibition, affinity screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest flavonoid- and phenolic-associated activity profile, supporting cultivation as a conservation-compatible source for natural product antioxidant evaluation while clarifying the limits of in vitro evidence.
-
Tetrazolium (chloride) in Ischemic Tissue Assays
2026-09-07
Tetrazolium (chloride) converts dehydrogenase activity into a visible Tetrazolium Red signal for cell, brain, and cardiac viability studies. This guide translates the chemistry into practical tissue-staining and mitochondrial assay workflows, with optimization parameters and troubleshooting for ischemic injury research.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-05
A 2026 MedComm study defines a metabolic–immune circuit in colorectal cancer in which NAT1 restrains ENO1 activity and lactate production, while NAT1 loss promotes TRAF6-dependent stabilization of PD-L1. The findings connect glycolytic output with immune checkpoint regulation and provide a preclinical framework for studying how lactate metabolism may influence responses to PD-1 or PD-L1 blockade.
-
Lactate Workflows for Metabolic–Immune Research
2026-09-04
Use L-lactate as both a quantitative metabolic readout and a controlled signaling input across glycolysis, hypoxia, mitochondrial, and tumor–immune experiments. This workflow-oriented guide connects careful compartmental sampling with the NAT1–ENO1–lactate mechanism and practical controls for reproducible cell-based assays.
-
A-769662: Designing Better AMPK Assays
2026-09-04
A-769662 is a reversible AMPK activator for dissecting energy metabolism, autophagy, and proteasome-linked phenotypes. This guide translates recent AMPK–ULK1 findings into practical assay-design and interpretation strategies.
-
WST-8 Glucose Uptake Assay Kit Workflow
2026-09-03
Build a non-radioactive glucose uptake assay around 2-deoxyglucose transport, enzymatic amplification, and 450 nm colorimetric detection. This workflow connects Galectin-1–FIP200 biology with functional insulin-resistance measurements while highlighting controls, normalization, and troubleshooting for hepatic steatosis models.
-
BI 2536: A Better Way to Read PLK1 Responses
2026-09-03
BI 2536 is a potent PLK1 inhibitor for dissecting mitotic arrest, apoptosis, and drug response. This guide combines PLK1 biology with a quantitative assay framework that distinguishes growth suppression from true cancer-cell killing.
-
Wnt-Driven Bone Disease Meets Live-Cell Screening
2026-09-02
Sclerosteosis illustrates how excessive Wnt/β-catenin signaling can convert a mechanistic insight into a difficult translational problem. This article explains how a Resazurin Cell Viability Assay Kit can help researchers separate treatment-related loss of cell health from genuine changes in osteoblast differentiation during PORCN-inhibitor studies.
-
Caspase-4 Colorimetric Assay Kit in Pyroptosis
2026-09-02
The Caspase-4 Colorimetric Assay Kit provides a practical way to quantify LEVD-dependent caspase-4 activity while separating inflammatory cell-death mechanisms from upstream organelle stress. This article connects ER-targeted peptide self-assembly with assay design, controls, interpretation, and orthogonal validation for stronger pyroptosis research.